4//SEC Filing
Vandebroek Sophie V. 4
Accession 0000874716-24-000064
CIK 0000874716other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:00 PM ET
Size
9.2 KB
Accession
0000874716-24-000064
Insider Transaction Report
Form 4
Vandebroek Sophie V.
Director
Transactions
- Exercise/Conversion
Common Stock
2024-03-05$245.79/sh+1,404$345,089→ 2,620 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2024-03-05−1,404→ 0 totalExercise: $245.79Exp: 2029-05-07→ Common Stock (1,404 underlying) - Sale
Common Stock
2024-03-05$562.98/sh−1,404$790,427→ 1,216 total
Holdings
- 8,173(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents the weighted average price of the shares sold ranging from a low of $562.9801 to a high of $563.2160 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F2]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 6, 2020.
- [F3]Not applicable.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeother
Related Parties
1- filerCIK 0001442078
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 5:00 PM ET
- Size
- 9.2 KB